thrombosis are sufficiently frequent complications to compel some to include anticoagulant therapy in the routine management of cardiac decompensation. The fundamental cause of this tendency toward thrombosis has not been elucidated; hypercoagulability has been suggested but never clearly demonstrated.
It has been observed that the critical period for thrombotic complications is during diuresis and restoration of compensation.' The present study was therefore undertaken to examine day-to-day changes in blood viscosity during this treatment interval, to assess the role, if any, of these changes in the tendency toward thrombosis. Measurements were made at the height of the congestive syndrome and were repeated at frequent intervals as compensation was restored. Attempts were made to correlate the changes encountered with alterations in hematocrit level, plasma volume, and fibrinogen concentration.
Problems inherent in the measurement of blood viscosity have been amply reviewed by others.2 4 Inasmuch as blood is a "non-Newtonian" suspension of erythrocytes in a 7per cent protein solution, the viscosity of this fluid, by definition, is dependent upon the rate Presented in part at the Thirty-sixth Scientffic Sessions of the American Heart Association, Los Angeles, California, October 1963. 686 of shear, which is a gradient of velocity between contiguous fluid layers. Because there is extreme variation in flow rate and vessel caliber in addition to the effects of axial streaming, there exists a spectrum of viscosity values throughout the vascular tree. This problem is partially circumvented with the Brookfield cone-plate viscometer employed in this study; with this method shear stress, which may be simply defined as the resistance to flow, is measured over a physiologically important range of shear rates. Viscosity is derived from the ratio of shear stress to shear rate.
Materials and Methods
Blood viscosity was measured in 30 subjects with congestive heart failure due to various types of heart disease. All of the subjects were admitted with the classic syndrome of "low-output" cardiac decompensation; all had cardiomegaly, dyspnea, edema, and an increase in venous pressure. Pertinent clinical information is included in table 1. Treatment included digitalis, salt restriction, and bed rest; diuretic agents were administered as necessary. One 500-ml. phlebotomy was performed in patient G.Y. Patients with anemia, cor pulmonale, severe renal disease, and thyrotoxicosis were excluded from the study.
Measurements were made at the bedside with the patient in the recumbent posture. Insofar as possible venous stasis was minimized. After blood samples for hematocrit and fibrinogen determinations were obtained, a 3-ml. sample was withdrawn in a siliconized syringe for blood viscosity measurement with a Brookfield cone plate viscometer, as modified by Wells et al.5 The principles, procedure, and calculations involved have been clearly stated by these investigators.5 In brief, this is a torque measuring device that involves the rotation of a flat cone upon a plane surface or plate. A sample of fluid in this system provides resistance to rotation of the cone, which is measured as torque in the spindle or drive-shaft of the cone. The degree of resistance provided Circulation. Volume XXX, November 1964 by the fluid is a function of its shear stress. Measurements are made at four predetermined revolutions per minute of the cone or, by definition, shear rates. Viscosity of the interposed fluid may be calculated from the ratio of shear stress to shear rate. Replicate readings were obtained at each rate of shear; these were rejected if they failed to agree within one centipoise. The viscometer was calibrated daily with National Bureau of Standards H oil. Fibrinogen concentration was determined daily by the method of Ratnoff 6 in 20 subjects.
In five subjects blood volume was determined during decompensation and again following restoration of compensation. Radio-chromium-labeled erythrocytes served as a reference for the measurement of red cell mass, and plasma volume was estimated by this value and the venous hematocrit value. The purpose in this determination was twofold: to correlate changes in viscosity with relative alterations in plasma volume and red cell mass and to determine whether changes in fibrinogen concentration reflected actual alterations in total intravascular fibrinogen or merely the effects of changes in plasma volume and, therefore, hemoconcentration. Hematocrit values were determined in triplicate in calibrated Exax Wintrobe tubes. The tubes were spun at 3,000 r.p.m. in a Standard International centrifuge no. 2, which was approximately 1,800 x G. The values were read at the red cell-buffy coat interface and no correction factors were applied.
Results
The changes in hematocrit value, fibrinogen concentration, and viscosity at four rates of shear are presented in table 1. In the interest of brevity only the admission values, maximum values, and posttreatment "steadystate" values are included. However, a typical study showing day-to-day changes in viscosity, hematocrit value, and fibrinogen concentration is depicted in figure 1 .
Blood viscosity was normal or only slightly elevated in the majority of these decompen-22 ODA S Figure 1 Change in body weight, hematocrit level, fibrinogen concentration, and blood viscosity during treatment of cardiac decompensation; patient B.P. the mean values for blood viscosity in these untreated cardiac patients were 10.5, 7.9, 6.0, and 5.2 centipoise, respectively; the mean values for normal persons at these same shear rates are 8.8 6.5, 5.7, and 5.3 centipoise. The mean hematocrit value was 47.3 per cent and the mean fibrinogen concentration was 400 mg. per 100 ml. prior to the institution of treatment. These values were only slightly elevated; the mean hematocrit value in this laboratory is 43 per cent and the mean fibrinogen concentration is 330 mg. per 100 ml., with a range of 250 to 350 mg. per 100 ml. As the patients became edema-free, blood viscosity, hematocrit and fibrinogen concentration increased in practically every instance, the maximum increase tending to occur between the third and tenth days of treatment. cent, and 37.3 per cent at these respective rates of shear. The increase, therefore, was greater at lower shear rates; this was found to be a statistically significant difference (p < 0.01). The mean increase in viscosity at all shear rates was 41.7 per cent. These alterations are presented graphically in figure 2 as per cent change from the initial value. The hematocrit value increased in 28 of 30 subjects; the mean hematocrit value following treatment was 53.3, and 25 of 30 posttreatment values exceeded 50 per cent as contrasted with 7 of 30 prior to treatment. Circulation, Volum.e XXX, November 1964 These changes are shown graphically in figure  3 . Fibrinogen concentration increased in 16 of the 20 subjects in whom these measurements were made (p < 0.01). Following treatment the mean fibrinogen concentration was 525 mg. per 100 ml. and the posttreatment values exceeded 500 mg. per 100 ml. in 12 of 20 persons. Changes in fibrinogen are presented graphically in figure 4 . In 20 subjects these parameters were remeasured after this period of intensive diuresis when the patients had been edema-free for several days. In most instances blood viscosity, hematocrit, and fibrinogen concentration returned toward the initial values (table 1, fig. 1 ).
The relationship of the changes in viscosity to alterations in hematocrit and fibrinogen concentration is shown in figures 5, 6, and 7. In figure * an excessive loss of plasma volume. There was, therefore, a distinct rise in hematocrit level with compensation in every instance. In none of these subjects was there a significant increase in total circulating fibrinogen; the rise in fibrinogen concentration, at least in these five subjects, may be ascribed to the contraction of the plasma volume and resultant hemoconcentration. blood viscosity versus changes in fibrinogen concentration are plotted; again there is significant linearity (p < 0.01), indicating that increasing levels of fibrinogen were associated with commensurate increases in blood viscosity. In figure 7 the combined effect of erythrocytosis and hyperfibrinogenemia is examined; spatial configuration of the points represents plots of posttreatment viscosity at one shear rate (12 sec.-1) versus posttreatment hematocrit values, and the various symbols indicate general fibrinogen levels. Although the data are too meager for statistical confirmation, it is apparent that the relationship of hematocrit level to blood viscosity may be bilinear in that in the presence of hyperfibrinogenemia viscosity will be higher at all hematocrit levels, particularly at hematocrit values exceeding 52 per cent. Extreme elevations of blood viscosity were encountered only when erythrocytosis and significant hyperfibrinogenemia were both present.
The results of the measurements of blood volume before and after treatment in five subjects are recorded in table 2. In addition, changes in fibrinogen concentration are also shown; from these values and the plasma volume data total circulating fibrinogen was calculated. The blood volume decreased in all of these subjects after treatment. In three this decrease consisted of plasma volume alone; in two subjects the red cell mass also decreased moderately, but there was at the same time Circulation, Volume XXX, November 1964 Discussion These studies clearly indicate that blood viscosity increases significantly in subjects with congestive heart failure as compensation is restored. This change in viscosity is likely due to major alterations in the blood fibrinogen level and erythrocyte concentration incident to treatment.
The blood volume is significantly expanded in subjects with congestive heart failure. This expansion is "symmetrical" in that it includes the red cell mass as well as plasma volume.7 With diuresis and restoration of compensation, the blood volume contracts; however, this decrease, at least initially, consists predominantly of plasma volume (table 2). The net effect of this selective loss of plasma volume against the background of a symmetrically expanded initial blood volume is a significant erythrocytosis and rise in hematocrit level. Moreover, it is considered likely from the total circulating fibrinogen data in figure 3 rise in fibrinogen concentration with compensation occurs not as a result of increased production but rather as a consequence of hemoconcentration. In most of those subjects on whom observations were made in the postdiuresis period there was a gradual decline in blood viscosity, fibrinogen concentration, and hematocrit level. It is likely, therefore, that a new erythrocyte/plasma ratio ultimately is established, either as a result of delayed loss of red cells or re-expansion of an overly contracted plasma space. In any event, the critical period for hemoconcentration and the changes herein described is sharply limited, apparently due to the emergence of a new equilibrium between red cell mass and plasma volume. It is generally agreed that the chief determinant of shear stress or the resistance to flow of whole blood is the concentration of erythrocytes in plasma. Merrill et al.8 noted that the viscosity of erythrocytes suspended in plasma exceeds that of equal volumes of red cells suspended in saline or serum, and it was concluded that, at least at very slow rates of shear, the presence of fibrinogen influences whole blood viscosity. Studies in this labora-tory9 support this view. In the present study the increase in viscosity was significantly correlated with both hematocrit and fibrinogen changes (figs. 4 and 5). The compendium in figure 6 indicates that the relationship of blood viscosity to the hematocrit value is strongly influenced by the fibrinogen concentration, and there actually may be a bilinear relationship in these hematocrit/viscosity points or, at least, two distinct aggregations which are seemingly determined by the fibrinogen concentration. In any event, it is apparent that the viscosity tends to be higher at all hematocrit levels where hyperfibrinogenemia exists. Thus, all viscosity values at 12 sec.-' that exceeded 20 centipoise were associated with hematocrit values of 54 per cent or greater and fibrinogen levels in excess of 600 mg. per 100 ml.
Recent interest in the rheology of blood has centered largely on the problem in relation to coronary artery disease. Thus, Burch and DePasquale 10, 11 and Wells and Merrill 2 have suggested that a change in blood viscosity might be the immediate precipitating factor in coronary thrombosis. On the other hand, it has not been established that increased viscosity predisposes to thrombosis, nor is it clear that hyperfibrinogenemia activates or accelerates thrombosis. Nevertheless, the changes herein presented are consonant with the clinical observation that thrombo-occlusive complications occur most frequently during the active treatment phase of cardiac decompensation. Alterations in the flow properties of blood may merely propitiate rather than initiate intravascular thrombosis, although Dintenfass 12 has suggested that rouleaux formation and erythrocyte agglutination may constitute an early phase of thrombus formation. Translation of these data into meaningful terms regarding the rheologic behavior of blood in various portions of the vascular tree is imprecise. It is likely that the effect is a general one, although the more pronounced changes at slower shear rates suggest that blood in small arteries and arterioles would be most affected. Studies with much slower rates of shear would be necessary to reflect circumstances in areas where near-stagnant or "creeping" flow prevails. In this series of 30 patients one subject had a proved myocardial infarction, two had clinically acceptable ones, and two had pulmonary emboli; one patient developed abdominal pain, possibly due to intestinal ischemia. In one patient (I.G.) the rise in fibrinogen preceded by 24 hours clinical evidence of fatal myocardial infarction. Blood viscosity in these subjects with thrombo-occlusive complications was not inordinately high, whereas subjects with exceedingly high viscosity values remained free from these complications. Therefore, the role of abrupt changes in viscosity, hematocrit, and fibrinogen concentration in thrombogenesis has not been clearly established by these limited observations. The implied danger of rapid and excessive diuresis and the value of anticoagulant drugs would require confirmation from more elaborately controlled clinical studies.
Conclusions
Restoration of compensation in 30 persons with congestive heart failure was associated with a 41.7-per cent increase in blood viscosity. This change in viscosity was correlated with a significant increase in hematocrit (47.3 per cent to 53.3 per cent) and fibrinogen concentration (400 mg. per 100 ml. to 525 mg. per 100 ml. ).
The erythrocytosis and hyperfibrinogenemia associated with relief of the congestive state may be ascribed to the disproportionate decline in plasma volume in relation to red cell mass which occurs with diuresis. Thus, preand posttreatment total circulating fibrinogen was unchanged in spite of a rise in concentration in the five patients on whom these measurements were made.
The role of these changes in thrombogenesis was not clearly established.
